# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5270581 | 18 | INH | > | 50 | nM | ALA5252873 | nM | Homo sapiens | |||
2. | ALA5278465 | 33 | IC50 | > | 2 | uM | ALA5252873 | nM | Homo sapiens | |||
3. | ALA5288565 | 29 | IC50 | > | 2 | uM | ALA5252873 | nM | Homo sapiens | |||
4. | Selitrectinib (LOXO-195) | SELITRECTINIB | % of control | = | 10 | % | ALA5213057 | % | Homo sapiens | |||
5. | Lorlatinib | 8k, PF-06463922 | Ki | = | 17 | nM | ALA5213164 | 7.77 | nM | Homo sapiens | ||
6. | XMD8-92 | 18 | IC50 | = | 18 | uM | ALA5213122 | 4.75 | nM | Homo sapiens | ||
7. | MPS1-IN-1 | Mps1-IN-1 | IC50 | = | 3100 | nM | ALA5212773 | 5.51 | nM | Homo sapiens | ||
8. | ALA5175977 | 28 | IC50 | > | 10 | uM | ALA5165282 | nM | Homo sapiens | |||
9. | PF-543 | PF-543 | IC50 | > | 10 | uM | ALA5165282 | nM | Homo sapiens | |||
10. | ALA5188399 | 1 | Activity | <= | 70 | % | ALA5155256 | % | Homo sapiens | |||
11. | larotrectinib | LAROTRECTINIB | IC50 | = | 576 | nmol/L | ALA5150441 | 6.24 | nM | Homo sapiens | ||
12. | ALA5170855 | 17b | Activity | = | 0.1 | % | ALA5129165 | % | Homo sapiens | |||
13. | ALA4458435 | 23; PF-06700841 | INH | = | 82 | % | ALA4411556 | % | Homo sapiens | |||
14. | ALA4455923 | 48c | INH | < | 50 | % | ALA4405250 | % | Homo sapiens | |||
15. | BMS-690514 | BMS-690514 | Kd | < | 225 | nM | ALA4394545 | nM | Homo sapiens | |||
16. | ALA4559936 | (+/-)-6 | Activity | = | 100 | % | ALA4391617 | % | Homo sapiens | |||
17. | ALA4564973 | 50 | INH | = | 100 | % | ALA4389991 | % | Homo sapiens | |||
18. | ALA4555459 | 43 | INH | = | 100 | % | ALA4389514 | % | Homo sapiens | |||
19. | ALA4545456 | 24 | INH | = | 5 | % | ALA4387369 | % | Homo sapiens | |||
20. | Abemaciclib | ABEMACICLIB | INH | = | 2.4 | % | ALA4387369 | % | Homo sapiens |